Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Alcohols. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1498273A details microbial reduction for chiral alcohols. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN109576238A reveals efficient transaminase route for chiral beta-amino alcohols. Enables cost reduction and high-purity supply for pharmaceutical intermediates manufacturing.
Patent CN105316250A reveals Empedobacter brevis strain for high-purity chiral alcohols. Offers cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN103642849A details a high-yield Geotrichum candidum reduction method for chiral intermediates, offering significant cost and supply chain advantages.
Patent CN112481226B details solvent-tolerant ADH mutants for scalable production of chiral alcohols, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN108359649A reveals high-selectivity alcohol dehydrogenase mutants for synthesizing chiral biaryl alcohols, offering cost reduction and supply reliability.
Patent CN102154377B reveals ScCR enzyme for asymmetric reduction. Enables cost-effective manufacturing of pharmaceutical intermediates with self-regenerating cofactors.
Patent CN101052604A details a catalytic de-enrichment method for chiral substrates, offering cost-effective recycling of unwanted isomers for pharmaceutical intermediate manufacturing.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Discover advanced chiral pyridoxal catalysts for asymmetric aldol reactions. Enable cost reduction in fine chemical manufacturing with scalable, metal-free synthesis routes.
Patent CN1166672C details a novel Ru-H4-BINAP-diamine complex for asymmetric hydrogenation, offering high enantioselectivity and cost-effective manufacturing for chiral alcohol intermediates.
Patent CN1376659A reveals a safe metal borohydride reduction system for high-purity chiral intermediates, offering significant cost and supply chain advantages.
Patent CN108863787A details efficient asymmetric hydrogenation for chiral alcohols. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110508323B details a water-phase Henry reaction using a recyclable thermosensitive chiral copper catalyst, offering high enantioselectivity and simplified downstream processing for pharmaceutical intermediates.
Patent CN116102464B details asymmetric hydrogenation for high-purity chiral amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1124962A details novel chiral catalysts for high-ee alcohol production, offering scalable routes for API intermediates and cost-effective manufacturing solutions.
Analysis of patent CN105130842B reveals a novel heterogeneous catalyst for chiral amino alcohol synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.